NCT00001208View on ClinicalTrials.gov

Botulinum Toxin for the Treatment of Involuntary Movement Disorders

RecruitingOBSERVATIONAL

Enrollment

2,000

Participants

Timeline

Start Date

October 26, 1989

Conditions

Movement Disorders

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH